HyStem™

HyStem™ Vials

HyStem is thiol-modified hyaluronic acid (HA) and is a component of the HyStem hydrogel kit. HA is a glycosaminoglycan and a major constituent of the extracellular matrix (ECM). Cells can be encapsulated in HyStem; however, cells do not attach to HyStem-only hydrogels1. For applications where cell attachment is required, HyStem can be used in conjunction with ECM proteins such as laminin, collagen, or fibronectin2. HyStem can be purchased in two formats: a 7.5 ml kit, which includes 6 – 1 ml vials of HyStem and 3 – 0.5 ml vials of Extralink, or as individual 1 ml vials.

Gelation

Reconstituted HyStem remains liquid at 15 to 37°C. Without crosslinker, HyStem will form a hydrogel via disulfide bond formation; however, the gelation time is over twenty-four hours. The rate of disulfide bond formation is highly dependent upon the solution pH and the amount of oxygen present. If Extralink™ is used to crosslink HyStem, the gelation time is about twenty minutes with no low-temperature or low-pH steps. Diluting HyStem with phosphate-buffered saline (PBS) or cell-culture medium can increase its gelation time.

Volume

HyStem vials come as a 1 ml aliquot only.  

Hyaluronic Acid Source

The hyaluronic acid used to produce Glycosil™ and HyStem™ is made by a proprietary bacterial-fermentation process using bacillus subtilis as the host in an ISO 9001:2000 process www.biopolymer.novozymes.com. It is produced by Novozymes under the trade name HyaCare® and is 100% free of animal-derived raw materials and organic solvents remnants. No animal-derived ingredients are used in its production and it has very low protein levels and no exotoxins. Its production follows the European Pharmacopoeia.

References

  1. X. Z. Shu, Y. Liu, F. Palumbo, Y. Luo, G. D. Prestwich, “In Situ Crosslinkable Hyaluronan Hydrogels for Tissue Engineering,” Biomaterials, 25, 1339-1348 (2004).
  2. X. Z. Shu, S. Ahmad, Y. Liu, and G. D. Prestwich, “Synthesis and Evaluation of Injectable, In Situ Crosslinkable Synthetic Extracellular Matrices (sECMs) for Tissue Engineering,” J. Biomed Mater. Res. A, 79A(4), 901-912 (2006).